Sorry, you need to enable JavaScript to visit this website.

    Pfizer, PlaNet Finance Partner to Study Options for Expanding Access to Healthcare in China

    Collaboration aims to support the development of innovative healthcare solutions in China that are sustainable, socially responsible, and financially viable

    (BUSINESS WIRE)--Pfizer Inc and PlaNet Finance announced today that they will team up to conduct an in-depth research project on the healthcare needs of the working poor in China. The study will examine the availability and existing sources of medicines, patient purchasing patterns, and the level of access to medical services. The study ultimately aims to help both organizations identify models that may enhance and expand access to medicines and healthcare services for the working poor in China.

    The Chinese Ministry of Health recently released the results of its 4th National Health Survey, an extensive document covering healthcare patterns across the country. The Pfizer and PlaNet Finance collaboration is designed to solicit additional information from low-income populations in China to complement existing and planned government efforts to improve healthcare.

    Pfizer’s mission in China is to meet the diverse medical needs of the country’s population through a broad portfolio of innovative medicines and partnerships with local healthcare providers, academics, and government in order to support the rapid development of the country’s healthcare system.

    “Pfizer’s partnership with PlaNet Finance is aligned with the strategy to expand our geographic reach across China. I am extremely confident that this partnership will also achieve the broader aim of identifying unique and workable solutions for the diverse medical needs of patients in Emerging Markets,” stated Jean-Michel Halfon, President & General Manager of Pfizer’s Emerging Markets Business Unit. “This is another step forward under our Global Access program, which is unique in that we are taking a broad, holistic approach to understanding the various barriers to healthcare access, so that we can implement solutions that are effective and sustainable.”

    For over ten years, and in over 60 countries, PlaNet Finance has been active in development and financing in the microfinance and microinsurance sectors. “Healthcare plays a major role in the fight against poverty. PlaNet Finance understands this challenge and has developed specific programs which link microfinance to healthcare - leveraging existing microfinance institution (MFI) infrastructure to implement awareness and prevention campaigns for malaria, HIV/AIDS, and other diseases. PlaNet Finance has also developed sustainable life and health insurance solutions for low-income populations through its subsidiary PlaNet Guarantee dedicated to microinsurance,” explained PlaNet Finance President Jacques Attali. “We are very pleased to team up with Pfizer; this partnership will enhance our work in meaningful and lasting ways to reach out to such a vital part of Chinese society to determine their healthcare needs.”

    This collaboration with an international non-profit organization, expert in microfinance and microinsurance, marks another milestone for Pfizer in its goal to increase access to medicines for more patients in the developing world. The company reiterated its position to adopt strategies that are commercially viable and socially responsible.

    Pfizer and PlaNet Finance look forward to sharing the results of this research with the Chinese government, in order to maximize its impact and reach throughout the country.

    About Pfizer

    Pfizer Inc., founded in 1849, is dedicated to better health and greater access to healthcare for people and their valued animals. Every day, colleagues in more than 150 countries work to discover, develop, manufacture and deliver quality, safe and effective prescription medicines to patients.

    Pfizer began its business operations in China in the 1980s and is now one of the largest multinational pharmaceutical enterprises in the country, with a presence in over 100 cities nationwide. In 2008, Pfizer announced plans to expand its business in China and opened a new manufacturing facility in Dalian in China's Northeast Liaoning province in February 2009. Pfizer has been present in Dalian since 1989.

    www.pfizer.com

    About PlaNet Finance

    A world leader in microfinance, PlaNet Finance is an international non-profit organization with the mission to alleviate poverty through the development of microfinance and microinsurance. PlaNet Finance, based in Paris, has been active in developing the microfinance and microinsurance sectors for more than ten years and has an international network of 40 offices and programs running in more than 60 countries. PlaNet Finance has supported 1,500 microfinance institutions.

    PlaNet Finance has operated in China since February 2003 and has contributed significantly to improving the lives of nearly 100,000 people through technical assistance to microfinance institutions in China, the 2007 launch of Nanchong MicroCred, a pilot microfinance institution in Sichuan and subsidiary of China Limited MicroCred, and through support of Harbin Bank in its downscaling programs.

    PlaNet Finance China is based in Beijing and works with local partners in the Chinese microfinance industry.

    www.planetfinancegroup.org

    http://www.planetfinancechina.org

    Pfizer Media:
    Marco Winkler
    (646) 318-1264
    (212) 733-9313
    or
    PlaNet Finance:
    Audrey Le Blanc (PlaNet Finance)
    +33 1 49 21 26 35






    Sign up for the latest Pfizer Wire news alerts

    Receive real-time updates on Pfizer’s news delivered directly to your inbox.

    Our Pipeline: Potential Breakthroughs in the Making

    We're elevating our breakthroughs in a bold new way. Check out our new visualized product pipeline.

    Corporate Fact Sheet

    For more than 170 years, Pfizer has worked to make a difference for all who rely on us.

    Media Asset Library

    Click here to view our media asset library.

    Pfizer Logo

    Our logo is shorthand for everything Pfizer represents: an image that is instantly identifiable to our colleagues, patients, the external scientific community, and the public.

    Executive Leadership

    Meet the executive leadership team, our senior-most leadership and decision-making management body who focus on major financial, strategic, and operational decisions for the entire company.

    Stay up to date on the latest news and alerts through the Pfizer Wire

    Sign up to receive real-time updates on Pfizer’s news from the Pfizer Media Relations team delivered directly to your inbox. 

     

    Sign Up Now